Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review
Joon Oh Park, Do-Youn Oh, Chiun Hsu, Jen-Shi Chen, Li-Tzong Chen, Mauro Orlando, Jong Seok Kim, Ho Yeong Lim
Cancer Res Treat. 2015;47(3):343-361.   Published online 2015 May 18     DOI: https://doi.org/10.4143/crt.2014.308
Citations to this article as recorded by Crossref logo
Biliary tract cancer
Juan W Valle, R Katie Kelley, Bruno Nervi, Do-Youn Oh, Andrew X Zhu
The Lancet.2021; 397(10272): 428.     CrossRef
Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review
Changhoon Yoo, Sang Hyun Shin, Joon-Oh Park, Kyu-Pyo Kim, Jae Ho Jeong, Baek-Yeol Ryoo, Woohyung Lee, Ki-Byung Song, Dae-Wook Hwang, Jin-Hong Park, Jae Hoon Lee
Cancers.2021; 13(7): 1647.     CrossRef
Treatment of advanced gallbladder cancer: A SEER‐based study
Weipu Mao, Fang Deng, Dongyan Wang, Li Gao, Xiuquan Shi
Cancer Medicine.2020; 9(1): 141.     CrossRef
LINC01714 Enhances Gemcitabine Sensitivity by Modulating FOXO3 Phosphorylation in Cholangiocarcinoma
Sheng Shen, Jiwen Wang, Bohao Zheng, Ying Tao, Min Li, Yueqi Wang, Xiaoling Ni, Tao Suo, Houbao Liu, Han Liu, Jiwei Zhang
Molecular Therapy - Nucleic Acids.2020; 19: 446.     CrossRef
Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers
Jonathan D Mizrahi, Valerie Gunchick, Kabir Mody, Lianchun Xiao, Phanikeerthi Surapaneni, Rachna T Shroff, Vaibhav Sahai
World Journal of Gastrointestinal Oncology.2020; 12(1): 83.     CrossRef
Low immune index correlates with favorable prognosis but with reduced benefit from chemotherapy in gallbladder cancer
Jie Wang, Xiaobo Bo, Changcheng Wang, Yanlei Xin, Lingxi Nan, Rongkui Luo, Lingli Chen, Xiao Shi, Tao Suo, Xiaoling Ni, Han Liu, Sheng Shen, Min Li, Pinxiang Lu, Yueqi Wang, Houbao Liu
Cancer Science.2020; 111(1): 219.     CrossRef
Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers
Jonathan D Mizrahi, Valerie Gunchick, Kabir Mody, Lianchun Xiao, Phanikeerthi Surapaneni, Rachna T Shroff, Vaibhav Sahai
World Journal of Gastrointestinal Oncology.2020; 12(1): 83.     CrossRef
Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer
Mansi Arora, James M. Bogenberger, Amro Abdelrahman, Jennifer L. Leiting, Xianfeng Chen, Jan B. Egan, Aradhana Kasimsetty, Elzbieta Lenkiewicz, Smriti Malasi, Pedro Luiz Serrano Uson, Bolni Marius Nagalo, Yumei Zhou, Marcela A. Salomao, Heidi E. Kosiorek,
Cancer Chemotherapy and Pharmacology.2020; 85(6): 1063.     CrossRef
NUC-1031 in biliary tract cancer: from bench to bedside and back?
Lenka N. C. Boyd, Godefridus J. Peters, Geert Kazemier, Elisa Giovannetti
Cancer Chemotherapy and Pharmacology.2020; 85(6): 1011.     CrossRef
Targeting cancer stem cells in cholangiocarcinoma (Review)
Nicole Mcgrath, Jianyang Fu, Sophie Gu, Changqing Xie
International Journal of Oncology.2020; 57(2): 397.     CrossRef
Enhanced gemcitabine cytotoxicity with knockdown of multidrug resistance protein genes in human cholangiocarcinoma cell lines
Jiaqi Yang, David Sontag, Yuewen Gong, Gerald Y Minuk
Journal of Gastroenterology and Hepatology.2020;[Epub]     CrossRef
Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results
Makoto Ueno, Masafumi Ikeda, Takashi Sasaki, Fumio Nagashima, Nobumasa Mizuno, Satoshi Shimizu, Hiroki Ikezawa, Nozomi Hayata, Ryo Nakajima, Chigusa Morizane
BMC Cancer.2020;[Epub]     CrossRef
Combined treatment for locally advanced cholangiocellular liver cancer - the case report
A. N. Polyakov, Yu. I. Patyutko, A. Yu. Syskova, K. A. Romanova, I. S. Bazin, O. N. Sergeeva, E. R. Virshke, E. S. Makarov, E. Yu. Antonova, A. A. Kirshin, D. V. Podluzhnyi
Research and Practical Medicine Journal.2019; 6(4): 158.     CrossRef
Translating the ABC-02 trial into daily practice: outcome of palliative treatment in patients with unresectable biliary tract cancer treated with gemcitabine and cisplatin
J. Dierks, M. P. Gaspersz, A. Belkouz, J. L. A. van Vugt, R. J. S. Coelen, J. W. B. de Groot, A. J. ten Tije, W. G. Meijer, J. F. M. Pruijt, T. van Voorthuizen, D. J. van Spronsen, M. Rentinck, D. ten Oever, J. M. Smit, H. M. Otten, T. M. van Gulik, J. W.
Acta Oncologica.2018; 57(6): 807.     CrossRef
Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy
Jae Woo Lee, Yong-Tae Kim, Sang Hyub Lee, Jun Hyuk Son, Jin Woo Kang, Ji Kon Ryu, Dong Kee Jang, Woo Hyun Paik, Ban Seok Lee
Gut and Liver.2018; 12(1): 102.     CrossRef
Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients
Xiaobo Bo, Jie Wang, Tao Suo, Xiaoling Ni, Han Liu, Sheng Shen, Min Li, Yueqi Wang, Houbao Liu, Jiejie Xu
BMC Cancer.2018;[Epub]     CrossRef
Revision of bilateral self-expandable metallic stents placed using the stent-in-stent technique for malignant hilar biliary obstruction
Jun Hyuk Son, Hee Seung Lee, Sang Hyub Lee, Seungmin Bang, Jinwoo Kang, Woo Hyun Paik, Ji Kon Ryu, Yong-Tae Kim
Hepatobiliary & Pancreatic Diseases International.2018; 17(5): 437.     CrossRef
Aktueller Therapiealgorithmus des intrahepatischen cholangiozellulären Karzinoms
G. Lurje, J. Bednarsch, C. Roderburg, C. Trautwein, U. P. Neumann
Der Chirurg.2018; 89(11): 858.     CrossRef
Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer
Gaya Spolverato, Fabio Bagante, Cecilia G. Ethun, George Poultsides, Thuy Tran, Kamran Idrees, Chelsea A. Isom, Ryan C. Fields, Bradley Krasnick, Emily Winslow, Clifford Cho, Robert C. G. Martin, Charles R. Scoggins, Perry Shen, Harveshp D. Mogal, Carl Sc
World Journal of Surgery.2017; 41(1): 224.     CrossRef
Comparison of FOLFIRINOX Chemotherapy with Other Regimens in Patients with Biliary Tract Cancers: a Retrospective Study
Tulay Kus, Gokmen Aktas, Mehmet Emin Kalender, Alper Sevinc, Celaletdin Camci
Journal of Gastrointestinal Cancer.2017; 48(2): 170.     CrossRef
SVCT-2 determines the sensitivity to ascorbate-induced cell death in cholangiocarcinoma cell lines and patient derived xenografts
Changzheng Wang, Hongwei Lv, Wen Yang, Ting Li, Tian Fang, Guishuai Lv, Qin Han, Liwei Dong, Tianyi Jiang, Beige Jiang, Guangshun Yang, Hongyang Wang
Cancer Letters.2017; 398: 1.     CrossRef
Prospective multicenter phase II study of gemcitabine plus cisplatin in patients with unresectable gallbladder cancer
Yoshiki Hirooka, Takuya Ishikawa, Hiroki Kawashima, Eizaburo Ohno, Koji Nonogaki, Akira Kanamori, Takanori Hirai, Hiroki Uchida, Osamu Shirai, Hideki Ishikawa, Hidemi Goto
Cancer Chemotherapy and Pharmacology.2017; 80(1): 119.     CrossRef
CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy
Dae-Won Lee, Seock-Ah Im, Yu Jung Kim, Yaewon Yang, Jiyoung Rhee, Im Il Na, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, In Sil Choi, Do-Youn Oh, Jee Hyun Kim, Tae-You Kim, Yung-Jue Bang
Cancer Research and Treatment.2017; 49(3): 807.     CrossRef
Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients
Bum Jun Kim, Jaewon Hyung, Changhoon Yoo, Kyu-pyo Kim, Seong-Joon Park, Sang Soo Lee, Do Hyun Park, Tae Jun Song, Dong Wan Seo, Sung Koo Lee, Myung-Hwan Kim, Jin-hong Park, Hyungwoo Cho, Baek-Yeol Ryoo, Heung-Moon Chang
Cancer Chemotherapy and Pharmacology.2017; 80(1): 209.     CrossRef
Cholangiocarcinoma and its mimickers in primary sclerosing cholangitis
Jonghun John Lee, Sebastian T Schindera, Hyun-Jung Jang, Scott Fung, Tae Kyoung Kim
Abdominal Radiology.2017; 42(12): 2898.     CrossRef
Impact of radiation dose in postoperative radiotherapy after R1 resection for extrahepatic bile duct cancer: long term results from a single institution
Byoung Hyuck Kim, Eui Kyu Chie, Kyubo Kim, Jin-Young Jang, Sun Whe Kim, Do-Youn Oh, Yung-Jue Bang, Sung W. Ha
Oncotarget.2017; 8(44): 78076.     CrossRef
The efficacy and safety of different pharmacological interventions for patients with advanced biliary tract cancer: A network meta-analysis
Xin-Fang Sun, Zhi-Kuan He, Jin-Ping Sun, Quan-Xing Ge, Er-Dong Shen
Oncotarget.2017; 8(59): 100657.     CrossRef
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
Nai-Jung Chiang, Chiun Hsu, Jen-Shi Chen, Hsiao-Hui Tsou, Ying-Ying Shen, Yee Chao, Ming-Huang Chen, Ta-Sen Yeh, Yan-Shen Shan, Shiu-Feng Huang, Li-Tzong Chen
Scientific Reports.2016;[Epub]     CrossRef
Chemotherapy for advanced biliary tract carcinoma
Lawrence Chen, Chiehfeng Chen, Yun Yen, Ka-Wai Tam
Medicine.2016; 95(33): e4584.     CrossRef
The role of microRNAs in gallbladder cancer
GANGHUA YANG, LEI ZHANG, RUIXIANG LI, LIN WANG
Molecular and Clinical Oncology.2016; 5(1): 7.     CrossRef